图书简介
Chlamydia pneumoniae is now recognized as an important human pathogen. Chlamydia pneumoniae is involved in 5%-15% of community acquired pneumonias, and recent data indicate its relevance in severe pneumonia and as a respiratory pathogen in immunocompromised subjects. A causal role for Chlamydia pneumoniae in the initiation, exacerbations and promotion of asthma has been suggested. Approximately 5% of chronic bronchitis exacerbations have been attributed to Chlamydia pneumoniae infections, and chronic infection may facilitate access of other pathogens to the lower respiratory tract. Another field of potential great social impact is the possible involvement of Chlamydia pneumoniae in the pathogenesis of atherosclerosis and related cardiovascular diseases. This book presents the current state-of-the-art knowledge on Chlamydia pneumoniae infection and highlights future lines of research.
History of Chlamydia pneumoniae (TWAR).- Chlamydia pneumoniae: Culture Methods.- Serology for Chlamydia pneumoniae (TWAR).- Chlamydia pneumoniae: Molecular Biology Methods.- Chlamydia pneumoniae Infections: Applications of Laboratory Methods.- Chlamydia pneumoniae: How to Document Respiratory Infection.- Chlamydia pneumoniae: Epidemiology.- Pharmacological and Pharmacokinetic Basis of Chlamydia pneumoniae Treatment.- Chlamydia pneumoniae: Clinical Characteristics of Acute Respiratory Infections.- Are Atypical Pathogens Important for Patients with Community-Acquired Pneumonia?.- Immunology of Chlamydia pneumoniae.- Chronic Chlamydia pneumoniae Infections.- Chlamydia pneumoniae: A New Possible Cause of Asthma.- Chlamydia pneumoniae: An Important Pathogen in Chronic Bronchitis.- Chlamydia pneumoniae: A New Threat for HIV-infected Subjects.- Chlamydia pneumoniae: Epidemiology of a New Cardiovascular Risk Factor.- Chlamydia pneumoniae and Atherosclerosis: Mechanisms of Vascular Damage.- Chlamydia pneumoniae and Atherosclerosis: Animal Models.- Open and Controlled Intervention Trials for ?Unusual? Anti-Chlamydia pneumoniae Indications: Asthma, Atherosclerosis, Myocardial Infarction.- Clarithromycin Treatment of Helicobacter pylori and Chlamydia pneumoniae Infections Decreases Fibrinogen Plasma Level in Patients with Ischemic Heart Disease.- Antibiotic Treatment in Atherosclerosis and Myocardial Infarction.- A Controlled Intervention Study with Antibiotics in Symptomatic Coronary Patients Irrespective of Serology.- Open-Label Before-After Trials of Anti-Chlamydia pneumoniae Antibiotics in Asthma.- Treatment of Chronic Infection with Chlamydia pneumoniae in Asthma.- Chlamydia pneumoniae Infections in Children.- Perspectives and Perceptions on the Clinical Relevance of Chlamydia pneumoniae Infection.
Trade Policy 买家须知
- 关于产品:
- ● 正版保障:本网站隶属于中国国际图书贸易集团公司,确保所有图书都是100%正版。
- ● 环保纸张:进口图书大多使用的都是环保轻型张,颜色偏黄,重量比较轻。
- ● 毛边版:即书翻页的地方,故意做成了参差不齐的样子,一般为精装版,更具收藏价值。
关于退换货:
- 由于预订产品的特殊性,采购订单正式发订后,买方不得无故取消全部或部分产品的订购。
- 由于进口图书的特殊性,发生以下情况的,请直接拒收货物,由快递返回:
- ● 外包装破损/发错货/少发货/图书外观破损/图书配件不全(例如:光盘等)
并请在工作日通过电话400-008-1110联系我们。
- 签收后,如发生以下情况,请在签收后的5个工作日内联系客服办理退换货:
- ● 缺页/错页/错印/脱线
关于发货时间:
- 一般情况下:
- ●【现货】 下单后48小时内由北京(库房)发出快递。
- ●【预订】【预售】下单后国外发货,到货时间预计5-8周左右,店铺默认中通快递,如需顺丰快递邮费到付。
- ● 需要开具发票的客户,发货时间可能在上述基础上再延后1-2个工作日(紧急发票需求,请联系010-68433105/3213);
- ● 如遇其他特殊原因,对发货时间有影响的,我们会第一时间在网站公告,敬请留意。
关于到货时间:
- 由于进口图书入境入库后,都是委托第三方快递发货,所以我们只能保证在规定时间内发出,但无法为您保证确切的到货时间。
- ● 主要城市一般2-4天
- ● 偏远地区一般4-7天
关于接听咨询电话的时间:
- 010-68433105/3213正常接听咨询电话的时间为:周一至周五上午8:30~下午5:00,周六、日及法定节假日休息,将无法接听来电,敬请谅解。
- 其它时间您也可以通过邮件联系我们:customer@readgo.cn,工作日会优先处理。
关于快递:
- ● 已付款订单:主要由中通、宅急送负责派送,订单进度查询请拨打010-68433105/3213。
本书暂无推荐
本书暂无推荐